<DOC>
	<DOC>NCT01226615</DOC>
	<brief_summary>The main purposes of this study are: - to determine the effects of chondroitin sulphate on brain response to pain assessed through fMRI in patients with knee osteoarthritis. - to investigate the relationship between treatment response detected by fMRI and the results of the different parameters of clinical assessment.</brief_summary>
	<brief_title>Assessment of the Effects of Chondroitin Sulphate in Patients With Knee Osteoarthritis With Functional Magnetic Resonance Imaging (fMRI)</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<criteria>Primary knee OA according to ACR criteria OA of radiological stages 2 to 3 according to KellgrenLawrence Estable knee pain during the last months before to start the clinical trial Patients with pain as the VASâ‰¥50mm at baseline Patients with skin conditions that could interfere in the clinical trial evaluation Pregnant or breastfeeding woman Patients with a history of alcoholism or other drug abuse Patients with an uncontrolled active psychiatric disorder Patients with other inflammatory or systemic conditions affecting other joints Patients who suffer more intense pain in the joint in another location Patients unable to differentiate between symptoms caused by the knee in front of the joint study opposite OA of radiological stages 1 or 4 according to KellgrenLawrence Other bone and articular diseases such as chondrocalcinosis, Paget's disease, rheumatoid arthritis, aseptic osteonecrosis, gout, septic arthritis, ochronosis, acromegaly, hemochromatosis, Wilson's disease, osteochondromatosis Patients with contraindications to perform an MRI such as: certain tattoos, pacemakers, intracranial clips incompatible with MRI, in the heart valves, hearing aids and other types of implants are incompatible with MRI Known allergy to chondroitin sulphate Washout period for OA treatments before beginning the study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Chondroitin sulphate</keyword>
	<keyword>Knee osteoarthritis</keyword>
	<keyword>Functional Magnetic Resonance Imaging</keyword>
</DOC>